Azido-PEG6-amine

What We Offer

Azido-PEG6-amine

Azido-PEG6-amine | 957486-82-7

Catelog Number R14-0265
Category Azides
Molecular Formula C14H30N4O6
Molecular Weight 350.41
Catalog Number Size Price Quantity
R14-0265 -- $--

Product Introduction

Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Azido-PEG6-amine is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Chemical Information

Synonyms O-(2-Aminoethyl)-O'-(2-azidoethyl)pentaethylene Glycol; N3-PEG6-CH2CH2NH2; 20-azido-3,6,9,12,15,18-hexaoxaicosan-1-amine; N3-PEG6-NH2
Purity ≥95%
IUPAC Name 2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine
Canonical SMILES C(COCCOCCOCCOCCOCCOCCN=[N+]=[N-])N
InChI InChI=1S/C14H30N4O6/c15-1-3-19-5-7-21-9-11-23-13-14-24-12-10-22-8-6-20-4-2-17-18-16/h1-15H2
InChI Key VCQSTKKJKNUQBI-UHFFFAOYSA-N
Solubility Soluble in DCM, DMF, DMSO, Water
Appearance Pale Yellow or Colorless Oily Matter
LogP 0.50806

Product Specification

Storage Store at -20°C, keep in dry and avoid sunlight
Signal Warning
GHS Hazard Statements H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statement Codes P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (The corresponding statement to each P-code can be found at the GHS Classification page.)

Computed Properties

XLogP3 -0.7
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 9
Rotatable Bond Count 20
Exact Mass 350.21653469 g/mol
Monoisotopic Mass 350.21653469 g/mol
Topological Polar Surface Area 95.8Ų
Heavy Atom Count 24
Formal Charge 0
Complexity 292
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication NumberTitlePriority Date
WO-2022219409-A2 Compositions containing nucleic acid nanoparticles and processes related to alteration of their physicochemical characteristics 2021-04-15
WO-2022162549-A2 Immunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their uses 2021-01-27
US-2022143231-A1 Macrocyclic compounds and methods of use thereof 2020-11-10
WO-2022101771-A1 Macrocyclic compounds and methods of use thereof 2020-11-10
US-2022072141-A1 Protein-drug conjugates comprising camptothecin analogs and methods of use thereof 2020-07-13
cartIcon
Inquiry Basket